Yasuhiro Torikoshi

Title: Yasuhiro Torikoshi: Innovator in Cancer Treatment Technologies

Introduction

Yasuhiro Torikoshi is an inventor based in Toyonaka-shi, Japan. He is known for his contributions to the field of cancer treatment technologies. Although he currently holds no granted patents, his innovative work focuses on methods for assessing the efficacy of cancer therapies.

Latest Patent Applications

Yasuhiro Torikoshi has filed several notable patent applications. One of his latest applications is titled "METHOD FOR DETERMINING SENSITIVITY OF TUMOR CELLS TO DASATINIB AND COMPUTER PROGRAM." This invention provides a method for determining the sensitivity of tumor cells to dasatinib by evaluating the inhibitory capacity of a predetermined tyrosine kinase inhibitor in a measurement sample prepared from a biological sample containing tumor cells, along with a computer program.

Another significant application is "METHOD FOR ASSESSING EFFICACY OF COMBINATION CHEMOTHERAPY, AND PROGRAM AND DEVICE FOR ASSESSING THE SAME." This method involves a two-step process for obtaining specific activity values of Cyclin Dependent Kinase (CDK) 1 and CDK2 in a biological sample from a cancer patient. It also includes assessing the efficacy of combination chemotherapy based on these values and the GSTπ expression level obtained from the sample.

Conclusion

Yasuhiro Torikoshi is making strides in the field of cancer treatment through his innovative patent applications. His work aims to enhance the understanding and effectiveness of cancer therapies, contributing to advancements in medical technology.